HeimANW • FRA
add
Immuron Ltd
Við síðustu lokun
0,040 €
Dagbil
0,040 € - 0,040 €
Árabil
0,032 € - 0,11 €
Markaðsvirði
16,32 m. AUD
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
ASX
Viðskiptafréttir
Seeking Alpha
fyrir 33 mínútum
Seasonal setup suggests S&P 500 will step higher into the new year: LPL
0,38%
0,50%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (AUD) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 1,27 m. | 108,61% |
Rekstrarkostnaður | 2,56 m. | 79,40% |
Nettótekjur | -2,43 m. | -169,00% |
Hagnaðarhlutfall | -190,94 | -28,94% |
Hagnaður á hvern hlut | — | — |
EBITDA | -1,68 m. | -118,52% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (AUD) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 11,66 m. | -32,07% |
Heildareignir | 15,55 m. | -29,28% |
Heildarskuldir | 2,84 m. | 19,79% |
Eigið fé alls | 12,71 m. | — |
Útistandandi hlutabréf | 228,00 m. | — |
Eiginfjárgengi | 0,66 | — |
Arðsemi eigna | -27,02% | — |
Ávöxtun eigin fjár | -32,61% | — |
Peningaflæði
Breyting á handbæru fé
| (AUD) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -2,43 m. | -169,00% |
Handbært fé frá rekstri | -1,94 m. | -141,79% |
Reiðufé frá fjárfestingum | 87,03 þ. | 1.082,80% |
Reiðufé frá fjármögnun | 12,00 þ. | 203,57% |
Breyting á handbæru fé | -1,78 m. | -170,36% |
Frjálst peningaflæði | -1,03 m. | -197,20% |
Um
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Stofnsett
1994
Höfuðstöðvar
Vefsvæði
Starfsfólk
7
